Key result
The interventional treatment of coronary artery disease has developed rapidly in China, with improvements in reperfusion strategies, clinical pathways, and the use of domestic drug-eluting stents.
This review highlights the rapid growth of PCI in China while identifying key areas for systemic improvement, such as pre-hospital transport and standardized STEMI pathways.
Answers are grounded in this paper and cite their sources.
May inform expansion of interventional cardiology in China; leaves open prospective validation of pathways and outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Weifeng Shen (2008) conducted a review in Coronary artery disease. Percutaneous coronary intervention (PCI) was evaluated. The interventional treatment of coronary artery disease has developed rapidly in China, with improvements in reperfusion strategies, clinical pathways, and the use of domestic drug-eluting stents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: